What's new

Human medicines European public assessment report (EPAR): Caprelsa, vandetanib, Date of authorisation: 16/02/2012, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Caprelsa, vandetanib, Date of authorisation: 16/02/2012, Revision: 29, Status: Authorised

Jun 25, 2025 - 11:10
 0
Human medicines European public assessment report (EPAR): Caprelsa, vandetanib, Date of authorisation: 16/02/2012, Revision: 29, Status: Authorised
Human medicines European public assessment report (EPAR): Caprelsa, vandetanib, Date of authorisation: 16/02/2012, Revision: 29, Status: Authorised
Read More

Tags:

Previous Article

Some vaccines may offer double protection against dementia, study suggests

Next Article

EMEA-003576-PIP01-24

Related Posts

European Shortages Monitoring Platform (ESMP): Implemen...

May 13, 2025  0

Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 24, 2025  0

Public engagement highlights 2024

May 19, 2025  0